LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, provided an update on its participation at HLTH Europe 2026, one of the healthcare industry's leading conferences focused on innovation and digital health. The company stated that attendance at the conference offered direct engagement with healthcare innovators, technology companies, providers, insurers, and digital health organizations from Europe, Latin America, and other international markets.
Management noted that HLTH Europe increased awareness of LataMed's developing healthcare technology platform among a broad range of industry participants. The company believes engagement with global healthcare stakeholders is an important component of its long-term strategy as it continues to advance its integrated healthcare ecosystem throughout Latin America. The conference reinforced management's belief that healthcare systems increasingly require integrated digital solutions capable of improving patient accessibility, care coordination, financial accessibility, and operational efficiency.
Management observed growing interest across the healthcare sector in artificial intelligence applications, telehealth infrastructure, healthcare payments, insurance accessibility initiatives, and technology-enabled patient engagement solutions. The company believes many of the themes discussed align closely with its ongoing efforts to develop an integrated healthcare ecosystem that combines telehealth infrastructure, healthcare coordination technologies, payment accessibility initiatives, insurance integration opportunities, pharmacy-related services, and AI-driven healthcare solutions.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “HLTH Europe provided an outstanding opportunity to engage with healthcare and technology professionals from across Europe, Latin America, and other international markets. One of the most encouraging takeaways from the conference was the growing industry focus on integrated healthcare platforms that combine accessibility, coordination, financial solutions, and technology-enabled patient engagement. We believe many of these trends align closely with the direction of our broader healthcare ecosystem strategy and reinforce our long-term vision for LataMed AI.”
The company noted that the conference also provided valuable visibility for its platform initiatives and an opportunity to establish new industry relationships that may support future growth objectives. LataMed AI is currently reviewing and evaluating various follow-up opportunities resulting from discussions held during the conference and intends to provide additional updates regarding any material developments as appropriate.
The implications of this announcement are significant for the digital health industry, particularly in emerging markets. The growing emphasis on integrated platforms suggests that healthcare providers and insurers are seeking comprehensive solutions that address multiple pain points, from access to payment. LataMed AI's focus on Latin America positions it to potentially capitalize on these trends, though the company remains in the development stage. The strategic engagements at HLTH Europe could lead to collaborations that accelerate platform development and market entry.
Photographs and highlights from the company's attendance are available through LataMed AI's official Instagram page. For additional information, visit https://latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
